Results 121 to 130 of about 16,602 (194)

Effectiveness of transarterial drug-loaded microsphere chemoembolization against cholangiocarcinoma combined with obstructive jaundice. [PDF]

BMC Cancer
Jia B, Chen Y, Lin R, Yang J, Meng X, Meng X.   +5 more
europepmc   +1 more source

An Image-Guided Combination Strategy: Immediate Hepatic Arterial Infusion of Nivolumab Following Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma. [PDF]

Cancers (Basel)
Zhang S, Zheng Z, Zhang C, Liu X, Shi X, Ma W.   +5 more
europepmc   +1 more source

Transarterial radioembolization versus transarterial chemoembolization for tumor control and survival outcomes in early to intermediate stage hepatocellular carcinoma: systematic review and meta-analysis. [PDF]

World J Surg Oncol
Mirza W, Khan ZA, Bhatti ABH.
europepmc   +1 more source

Comparison of the Efficacy and Safety of Transarterial-Chemoembolization versus Radiofrequency-Ablation for Hepatocellular Carcinoma within Milan Criteria: A Propensity Score-Matching Study. [PDF]

J Hepatocell Carcinoma
Tang W, Huang Y, Wang T, Yang J, Zhao Z.
europepmc   +1 more source

Enhancing immune response in advanced HCC with PVTT: rivaroxaban as a core adjuvant in combined therapy. [PDF]

J Immunother Cancer
Yan Y, Zou D, Li Y, Ma H, Chen H.
europepmc   +1 more source

Prognostic effect and prognostic factors of TACE for the treatment of unresectable hepatocellular carcinoma: Propensity score matching analysis. [PDF]

Oncol Lett
Zhang L, Li C, Guo H, Zhang X, Liu W, Xu X.   +5 more
europepmc   +1 more source

Histone delactylation shapes epigenetic landscapes and therapeutic stratification in hepatocellular carcinoma. [PDF]

ILIVER
Wu Z, Li X, He Z, Li B, Xu Y, Hu W, Li J, Yao W, Liu Q, Gao X, Jiang T, Tian H.   +11 more
europepmc   +1 more source

Cerebral lipiodol embolism after transcatheter arterial chemoembolization for hepatocellular carcinoma: a case report and review of the literature. [PDF]

Front Oncol
Xu Z, Xia H.
europepmc   +1 more source

Transarterial chemoembolization combined with immunotherapy and targeted therapy as first-line treatment for unresectable and non-metastatic hepatocellular carcinoma: a meta-analysis of phase III trials. [PDF]

Ther Adv Gastroenterol
Wang L, Luo B, Zhao M, Shen J.
europepmc   +1 more source

Development and validation of a clinical-adipometric nomogram for predicting tumor response to transarterial chemoembolization in hepatocellular carcinoma. [PDF]

Sci Rep
Zhao J, Fu G, Wang Y, Yang H.
europepmc   +1 more source